Polpharma Pharmaceutical Works - API Manufacturer

drukuj

Environment & safety   

Respect for the natural environment is an integral part of our operating policy. We take all the possible actions in order to reduce the impact of manufacturing activities on the environment, and a secure safe workplace for our staff.


A company-wide project on environmental concerns has been set up to prepare for and implement the rich regulations into our processes.

 

Our Integrated Management System of Environmental Health and Safety complies with the strictest international standards.


ISO 14001 and OHSAS 18001/PN-N-18001 certification

 

We minimize our environmental impact by:

 

  • Reducing emissions
  • Controlling effluents with the most stringent regulations
  • Protecting surface and underground water    
  • Protecting the soil
  • Controlling noise pollution
  • Using natural resources rationally
  • Investing in environmental protection

We continuously improve the work environment by incorporating the best advances to provide for a safe workplace and minimize occupational hazards. At the same time, we invest in increasing the professional qualifications of the staff.

 

Polpharma possesses its own wastewater treatment plant for the chemical and biological treatment of wastewater as well as a waste incineration plant.

 


 

We use state-of-the-art environmental friendly technologies. All the manufacturing processes are adjusted to the requirements of the EU directive on integrated pollution prevention and control IPPC

 

 

 

 

 

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo